Company initiatives, Investments, Press Release

Lanxess invests in enzymes

Enzymes technology developer evocatal GmbH has completed a Series B financing round with new investors NRW.BANK and LANXESS as well as existing investors also taking part on the recent financing. The investments from this round of financing will be used to extend the firm’s technology platform as well as its product portfolio.

About Doris de Guzman

Will Green Chemistry save the world or is it hype? Doris de Guzman examines alternative processing, new technology, R&D and other sustainability initiatives aimed at preventing pollution; replacing ingredients; and using renewable feedstocks in Green Chemistry. She has been covering the oleochemicals market for 15 years and spread her beat to inorganics, biofuels and green chemistry.


Comments are closed.

Confirm if you are currently a subscriber to Tecnon OrbiChem's Bio-Materials newsletter. If not, please contact


Follow me on Twitter

%d bloggers like this: